Journal
CELLS
Volume 11, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/cells11071217
Keywords
YB-1; transcription factor; cancer; RNA binding protein; therapeutic target
Categories
Funding
- National Key R&D Program of China [2020YFA0112300, 2020YFA0803200]
- National Natural Science Foundation of China [U2102203, 82173014, 81830087, 81872414]
- CAS Light of West China program
- Yunnan Fundamental Research Projects [202001AW070018, 202101AS070050, 2019FB112]
- Reserve talents for Yunnan Province of Medical Science [H-2018078]
Ask authors/readers for more resources
Y box binding protein 1 (YB-1) is a versatile protein with important roles in gene transcription, RNA splicing, DNA damage repair, cell cycle progression, and immunity. Accumulating evidence suggests that YB-1 promotes tumor progression in various types of cancers and may serve as a potential therapeutic target.
Y box binding protein 1 (YB-1) is a protein with a highly conserved cold shock domain (CSD) that also belongs to the family of DNA- and RNA-binding proteins. YB-1 is present in both the nucleus and cytoplasm and plays versatile roles in gene transcription, RNA splicing, DNA damage repair, cell cycle progression, and immunity. Cumulative evidence suggests that YB-1 promotes the progression of multiple tumor types and serves as a potential tumor biomarker and therapeutic target. This review comprehensively summarizes the emerging functions, mechanisms, and regulation of YB-1 in cancers, and further discusses targeted strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available